welcome
CNBC

CNBC

Health

Health

Healthy Returns: The FDA approved fewer new drugs in 2024 — but some big ones hit the market

CNBC
Summary
Nutrition label

84% Informative

The U.S. Food and Drug Administration wrapped up 2024 with 50 new drug approvals.

There were several firsts and other notable medications that the agency gave a green light last year .

Many of the FDA approvals were for products from little known public and private companies, such as Allecra Therapeutics and BridgeBio Pharma.

Transcarent CEO Glen Tullman previously helmed Livongo , which was acquired by Teladoc in a 2020 agreement that valued the company at $18.5 billion .

"We're creating now an experience that people don't just like, they actually love," he said.

Small business owner?

Otherweb launches Autoblogger—a revolutionary way to bring more leads to any small business, using the power of AI.